[1] |
Feng QY, Wei Y, Chen JW, et al. Anti-EGFR and anti-VEGF agents: important targeted therapies of colorectal liver metastases[J]. World J Gastroenterol, 2014, 20(15): 4263-4275.
|
[2] |
Tang B, Liang W, Liao Y, et al. PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway[J]. Oncol Rep, 2019, 41(1): 43-56.
|
[3] |
Lindgren M, Rask G, Jonsson J, et al. Type IV collagen in human colorectal liver metastases—cellular origin and a circulating biomarker[J]. Cancers, 2022, 14(14): 3396.
|
[4] |
张敏, 冯怡锟, 张岩, 等. 结直肠腺癌组织中MMP2、ADAM17及E-cadherin的表达及临床意义[J]. 癌症进展, 2020, 18(4): 414-417.
|
[5] |
魏双琴, 李迎春, 张成, 等. MMP-7、MMP-9基因多态性与结直肠癌发病的关系研究[J]. 中国现代医学杂志, 2018, 28(2): 42-46.
|
[6] |
Barabás L, Hritz I, István G, et al. The behavior of MMP-2, MMP-7, MMP-9, and their inhibitors TIMP-1 and TIMP-2 in adenoma-colorectal cancer sequence[J]. Dig Dis, 2021, 39(3): 217-224.
|
[7] |
Böckelman C, Beilmann-Lehtonen I, Kaprio T, et al. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer[J]. BMC Cancer, 2018, 18(1): 679.
|
[8] |
郑香伟, 陈克河, 康继厚. Ataxin-3和MMP-11在伴肝转移结直肠癌组织中的表达及临床意义[J]. 临床肿瘤学杂志, 2019, 24(5): 401-405.
|
[9] |
Liu J, Xiao Q, Xiao J, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities[J]. Signal transduction and targeted therapy, 2022, 7(1): 3.
|
[10] |
李炜玉, 黄圆圆, 江志敏, 等. Wnt通路激活的结直肠癌细胞抑制肿瘤浸润性树突细胞成熟的机制研究[J]. 岭南现代临床外科, 2019, 19(2): 162-168.
|
[11] |
Cheng X, Xu X, Chen D, et al. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer[J]. Biomedicine & Pharmacotherapy, 2019, 110: 473-481.
|
[12] |
Sun K, He SB, Yao YZ, et al. Tre2 (USP6NL) promotes colorectal cancer cell proliferation via Wnt/β-catenin pathway[J]. Cancer Cell International, 2019, 19: 1-12.
|
[13] |
Tang Q, Chen J, Di Z, et al. TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer[J]. Journal of Experimental & Clinical Cancer Research, 2020, 39(1): 232.
|
[14] |
Fei R, Wei QS, Xiang D. CD133: A cancer stem cells marker, is used in colorectal cancers[J]. World Journal of Gastroenterology, 2013, 19(17): 2603-2611.
|
[15] |
Grosse-Gehling P, Fargeas CA, Dittfeld C, et al. CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges[J]. The Journal of Pathology, 2013, 229(3): 355-378.
|
[16] |
Nguyen PH, Giraud J, Chambonnier L, et al. Characterization of biomarkers of tumorigenic and chemoresistant cancer stem cells in human gastric carcinomabiomarkers of tumorigenic and chemoresistant gastric CSCs[J]. Clinical Cancer Research, 2017, 23(6): 1586-1597.
|
[17] |
Wang W, Wan P, Lai F, et al. Double-stranded RNA targeting calmodulin reveals a potential target for pest management of Nilaparvata lugens[J]. Pest management science, 2018, 74(7): 1711-1719.
|
[18] |
Terraneo N, Jacob F, Peitzsch C, et al. L1 cell adhesion molecule confers radioresistance to ovarian cancer and defines a new cancer stem cell population[J]. Cancers, 2020, 12(1): 217.
|
[19] |
Mansoori B, Mohammadi A, Naghizadeh S, et al. miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer[J]. Journal of Cellular Physiology, 2020, 235(2): 920-931.
|
[20] |
Zhang Y, Ma LN, Xie Y. MiRNA-802 inhibits the metastasis of colorectal cancer by targeting FOXE1[J]. European review for medical and pharmacological sciences, 2020, 24(4): 1778-1785.
|
[21] |
陈贝贝, 吕慧芳, 别良玉, 等. MicroRNA-375表达对大肠癌细胞生物学特性的影响[J]. 现代肿瘤医学, 2017, 25(22): 3558-3563.
|
[22] |
杨秀春, 王盼, 余涛, 等. miRNA-107在胃癌、结直肠癌及其癌前病变中的表达水平及临床意义[J]. 中国中西医结合消化杂志, 2020, 28(1): 52-57.
|
[23] |
张学明, 裴永彬, 张峰, 等. 血浆微RNA-224在结直肠癌中的诊断价值[J]. 肿瘤, 2014, 34(7): 623-628.
|
[24] |
Bhattacharya R, Ye XC, Wang R, et al. Intracrine VEGF signaling mediates the activity of prosurvival pathways in human colorectal cancer cells[J]. Cancer research, 2016, 76(10): 3014-3024.
|
[25] |
Bhattacharya R, Fan F, Wang R, et al. Intracrine VEGF signalling mediates colorectal cancer cell migration and invasion[J]. British journal of cancer, 2017, 117(6): 848-855.
|